A Cross- Sectional study of Admitted Neonates for Therapy with Jaundice Through the year 2019 as a Result of ABO Incompatibility at Tarhuna Educational Hospital

Tawfg  Omar Abdlmola; Ali Guma Azbida

doi:10.71147/xfeaez29

المؤلفون

Tawfg Omar Abdlmola Department of medical laboratory, Faculty of Medical technology, Azzaytuna University -Libya. Author
Ali Guma Azbida Department of medical laboratory, Faculty of Medical technology, Azzaytuna University -Libya Author

DOI:

https://doi.org/10.71147/xfeaez29

الكلمات المفتاحية:

Neonates, Jaundice, ABO, Neonates Incompatibility

الملخص

One of the most common causes of neonatal jaundice is ABO incompatibility. Maternal fetal ABO blood group incompatibility, in which the mother has blood group O and the newborn has blood group A and B occurs in 15-20% of all pregnancies. The jaundice of neonates due to ABO incompatibility is one of the problems that newborns suffer during the first week of their lives. The study aims: to find out the prevalence of jaundice due to ABO incompatibility in the Tarhuna Education Hospital. Material and method: A number of 214 newborns have been studied at Tarhuna Education Hospital from January to December 2019. Information was collected from the archive through a form on the information on the disease. Data were analyzed by Microsoft Excel 2007 for percentages. Result: Through the results obtained, it was found that (58.88%) the neonate was male and (41.12%) females from 214 hospitalized neonates. The percentage of neonates without jaundice was (%53.27), while the total of jaundiced neonates represented (46.73%). There was (%29.91) of neonatal jaundice due to other causes while (16.82%) of them as a result of ABO incompatibility. Conclusion: It has been found that (16.82%) jaundiced neonates due to ABO incompatibility and jaundice neonate due to other case (29.9%). jaundiced neonates as a result of ABO incompatibility in mothers blood group O+ most occurs exclusively in infant with baby's blood group A + which showed 44.44% while B+ and A- represented (16.67 %) and (13.89 %) respectively.

المراجع

Abbas, S. H., Nafea, L. T., & Abbas, R. S. (2020). Prevalence of ABO Incompatibility and its effect on Neonates Hyperbilirubinemia. Research Journal of Pharmacy and Technology, 13(1)141-146.‏ Retrieved from: https://rjptonline.org/HTMLPaper.aspx?Journal=Research%20Journal%20of%20Pharmacy%20and%20Technology;PID=2020-13-1-28

Adoba, P., Ephraim, R. K., Kontor, K. A., Bentsil, J. J., Adu, P., Anderson, M., ... & Nsiah, P. (2018). Knowledge Level and Determinants of Neonatal Jaundice: A Cross‐Sectional Study in the Effutu Municipality of Ghana. International Journal of Pediatrics, 2018(1), 3901505.. https://doi.org/10.1155/2018/3901505.

Akgül, S., Korkmaz, A., Yiğit, S., & Yurdakök, M. (2013). Neonatal hyperbilirubinemia due to ABO incompatibility: does blood group matter?. The Turkish journal of pediatrics, 55(5), 506–509. Retrieved from: https://pubmed.ncbi.nlm.nih.gov/24382531/

American Academy of Pediatrics Subcommittee on Hyperbilirubinemia (2004). Management of Hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics, 114(1), 297–316. doi.org/10.1542/peds.114.1.297

Chen, S. H., Lin, M., Yang, K. L., Lin, T. Y., Tsai, H. H., & Wang, T. F. (2012). Association of ABO incompatibility with red blood cell indices of cord blood unit. Pediatrics & Neonatology, 53(2),138-143. ‏doi.org/10.1016/j.pedneo.2012.01.012.

Erlichman, J., Loomes, K. M., & Rand, E. B. (2016). Causes of cholestasis in neonates and young infants. Dostupnona: https://www. uptodate.com

Hameed, N. N., Jehad, H. N., & Salih, A. A. (2011). ABO incompatibility in newborn babies. J Fac Med Baghdad, 53(4). Retrived from https://iqjmc.uobaghdad.edu.iq/index.php/19JFacMedBaghdad36/article/view/789

Inamori, G., Kamoto, U., Nakamura, F., Isoda, Y., Uozumi, A., Matsuda, R., ... & Ota, H. (2021). Neonatal wearable device for colorimetry-based real-time detection of jaundice with simultaneous sensing of vitals. Science advances, 7(10), eabe3793. doi.org/10.1126/sciadv.abe3793

Kimball, C. (2019). ABO Incompatibility in the Newborn. Journal of Neonatology, 33(1-4), 22-25.‏ doi.org/10.1177/0973217919908368

Li, Q., Deng, X., Yan, J., Sun, X., Dong, X., Chen, X., ... & Yu, Z. (2021). Neonatal Severe Hyperbilirubinemia Online Registry in Jiangsu Province: protocol for a multicentre, prospective, open, observational cohort study. BMJ open, 11(2), e040797. https://doi.org/10.1136/bmjopen-2020-040797.

Mitra, S., & Rennie, J. (2017). Neonatal jaundice: aetiology, diagnosis and treatment. British journal of hospital medicine (London, England:2005), 78(12),699–704. https://doi.org/10.12968/hmed.2017.78.12.699.

Nagashree, U., Swetha, P., Manohar, S., & Parthasarathy, L. K. (2019). ABO incompatibility: its impact on pregnancy and neonate. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 8(2), 766-768.‏ doi.org/10.18203/2320-1770.ijrcog20190321.

Patel, A. S., Desai, D. A., & Patel, A. R. (2017). Association of ABO and Rh incompatibility with neonatal hyperbilirubinaemia. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 6(4), 1368-75.‏DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog201 71393.

Saeed, I. S., Jumaa, R. S., & AL-Swaf, F. B. (2009). Hemolytic disease of newborn due to ABO incompatibility. The Medical Journal of Tikrit University, 2(152).

Tanyer, G., Siklar, Z., Dallar, Y., Yildirmak, Y., & Tiraş, U. (2001). Multiple dose IVIG treatment in neonatal immune hemolytic jaundice. Journal of tropical pediatrics, 47(1), 50–53. doi: 10.1093/tropej/47.1.50